Literature DB >> 9214696

Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins.

L Belguendouz1, L Fremont, A Linard.   

Abstract

Resveratrol, a phytoalexin (3, 4', 5, trihydroxystilbene) present in some red wines, has been reported to inhibit copper-mediated low-density lipoprotein (LDL) oxidation. In this study, we examined the efficiency of this compound in inhibiting metal ion-dependent and independent peroxidation of porcine LDL. At 0.5, 1, or 1.5 microM, transresveratrol prolonged the lag time preceding the onset of conjugated diene formation in a dose-dependent manner, with a slope of the propagation phase 5-fold greater in the presence of Cu SO4 (5 microM) than in the presence of the free radical generator, AAPH [2, 2'-azobis (2-amidinopropane) dihydrochloride] (1 mM). At 1 microM, transresveratrol prolonged the lag time 3.4- and 1.4-fold in the presence of copper and AAPH, respectively. Isomerisation into cisresveratrol significantly lowered the chelating capacity, but did not alter the free radical scavenging capacity. As compared to flavonoids and trolox, transresveratrol showed a much higher ability to prolong the lag time in copper, but not in AAPH-catalyzed oxidation. The kinetics of generation of degradative products in the presence of copper confirmed the strongest protective effects of transresveratrol, because the formation of thiobarbituric acid reactive substances and hydroperoxides was almost completely inhibited at 200 min. By contrast, transresveratrol was less potent than flavonoids (but more than trolox) as a scavenger of free radicals. Our data show that, like flavonoids, resveratrol protects LDL against peroxidative degradation by both chelating and free radical scavenging mechanisms. However, transresveratrol, which is by far the most potent chelator of copper, does not chelate iron. It might contribute to the protective effects of wine polyphenols by removing copper from LDL particles and arterial tissue and, thereby, delaying the consumption of flavonoids and endogenous antioxidants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9214696     DOI: 10.1016/s0006-2952(96)00820-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  38 in total

1.  Response of plasma lipids to dietary cholesterol and wine polyphenols in rats fed polyunsaturated fat diets.

Authors:  L Frémont; M T Gozzelino; A Linard
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

2.  Cardioprotection by resveratrol: a review of effects/targets in cultured cells and animal tissues.

Authors:  Joseph M Wu; Tze-Chen Hsieh; Zhirong Wang
Journal:  Am J Cardiovasc Dis       Date:  2011-04-27

3.  Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease.

Authors:  Saravanan S Karuppagounder; John T Pinto; Hui Xu; Huan-Lian Chen; M Flint Beal; Gary E Gibson
Journal:  Neurochem Int       Date:  2008-11-08       Impact factor: 3.921

Review 4.  Resveratrol and the eye: activity and molecular mechanisms.

Authors:  Christina Bola; Hannah Bartlett; Frank Eperjesi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-21       Impact factor: 3.117

5.  Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration.

Authors:  Balachandar Venkatesan; Anthony J Valente; Venkatapuram Seenu Reddy; Deborah A Siwik; Bysani Chandrasekar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-26       Impact factor: 4.733

6.  Reduction of blood cholesterol and ischemic injury in the hypercholesteromic rabbits with modified resveratrol, longevinex. [corrected]

Authors:  Bela Juhasz; Bela Juhaz; Dipak K Das; Attila Kertesz; Akos Juhasz; Rudolf Gesztelyi; Balazs Varga
Journal:  Mol Cell Biochem       Date:  2010-11-04       Impact factor: 3.396

7.  Protective effects of resveratrol on glutamate-induced damages in murine brain cultures.

Authors:  Rudolf Moldzio; Khaled Radad; Christopher Krewenka; Barbara Kranner; Johanna Catharina Duvigneau; Wolf-Dieter Rausch
Journal:  J Neural Transm (Vienna)       Date:  2013-03-05       Impact factor: 3.575

Review 8.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

Review 9.  Noise and quality of life.

Authors:  Michael D Seidman; Robert T Standring
Journal:  Int J Environ Res Public Health       Date:  2010-10-19       Impact factor: 3.390

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.